Patents by Inventor Rajeev Singh

Rajeev Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10722456
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: July 28, 2020
    Assignee: DR. REDDY'S LABORATORIES LTD
    Inventors: Sagar Munjal, Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20200222345
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 16, 2020
    Applicant: DR. REDDY'S LABORATORIES LTD.
    Inventors: Swati KULKARNI, Bijay Kumar PADHI, Shanvas ALIKUNJU, Rajeev Singh RAGHUVANSHI, Srinivas Ramchandra SIDGIDDI, Anirudh GAUTAM
  • Publication number: 20200171000
    Abstract: The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.
    Type: Application
    Filed: December 18, 2019
    Publication date: June 4, 2020
    Inventors: Prabhu Prabhakara, Rajesh Ramesh Patil, Piyush Gupta, Rajeev Singh Raghuvanshi, Anil N. Namboodiripad
  • Publication number: 20200085775
    Abstract: The present application relates to pharmaceutical compositions comprising retinoic acid or its derivatives such as isotretinoin and processes for preparing thereof. It also provides methods for treating acne by administering such pharmaceutical composition to a patient in need thereof.
    Type: Application
    Filed: November 21, 2019
    Publication date: March 19, 2020
    Inventors: Yogesh Bapurao PAWAR, Kailas KHOMANE, Saurabh SRIVASTAVA, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Publication number: 20200078378
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: April 18, 2019
    Publication date: March 12, 2020
    Applicant: Nestle Skin Health SA
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Rajeev Singh RAGHUVANSHI
  • Patent number: 10537554
    Abstract: The present application relates to a method of treating migraine or cluster headache in a human patient, said method comprising administering subcutaneously composition comprising sumatriptan or its pharmaceutically acceptable salt, in an amount equivalent to 3 mg sumatriptan base.
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: January 21, 2020
    Assignee: UPSHER-SMITH LABORATORIES, LLC
    Inventors: Prabhu Prabhakara, Rajesh Ramesh Patil, Piyush Gupta, Rajeev Singh Raghuvanshi, Anil N. Namboodiripad
  • Patent number: 10517846
    Abstract: The present application relates to pharmaceutical compositions comprising retinoic acid or its derivatives such as isotretinoin and processes for preparing thereof. It also provides methods for treating acne by administering such pharmaceutical composition to a patient in need thereof.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: December 31, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Yogesh Bapurao Pawar, Kailas Khomane, Saurabh Srivastava, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Patent number: 10376527
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: March 15, 2018
    Date of Patent: August 13, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Publication number: 20190224143
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: Chandrakant Bamtu VELIP, Anup Avijit CHOUDHURY, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • Publication number: 20190224219
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 29, 2019
    Publication date: July 25, 2019
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Publication number: 20190209500
    Abstract: The present application relates to a method of treating an inflammatory skin condition by administering a pharmaceutical composition comprising a reduced dose of minocycline to a subject in need thereof, wherein said administration provides an effective plasma or interstitial fluid concentration of minocycline for treating the inflammatory skin condition.
    Type: Application
    Filed: January 7, 2019
    Publication date: July 11, 2019
    Inventors: Swati KULKARNI, Bijay Kumar PADHI, Shanvas ALIKUNJU, Rajeev Singh RAGHUVANSHI, Srinivas Ramchandra SIDGIDDI, Anirudh GAUTAM
  • Patent number: 10300081
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: May 28, 2019
    Assignee: NESTLE SKIN HEALTH SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Patent number: 10292947
    Abstract: The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: May 21, 2019
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Chandrakant Bamtu Velip, Anup Avijit Choudhury, Girish Karanth, Rajeev Singh Raghuvanshi
  • Publication number: 20190000753
    Abstract: The present application relates to a nasal dosage form of dihydroergotamine, wherein said dosage form requires less than about 15 minutes for administration and requires less than four sprays to administer effective dose of dihydroergotamine for treating migraine in human subjects.
    Type: Application
    Filed: July 2, 2018
    Publication date: January 3, 2019
    Inventors: Aditya NARASIMHA MURTHY, Piyush GUPTA, Arun JANA, Vishal VALLABHADAS RATHI, Girish KARANTH, Rajeev Singh RAGHUVANSHI
  • Patent number: 10069738
    Abstract: A single cellular radio is enabled to support multiple phone lines and data service. The system can be split into two parts: a telephone adapter that receives input from one or more phone lines, and a wireless hot spot communicably coupled to one or more telephone adapters that transmits communications associated with the phone lines and data service to the mobile network. The telephone adapter can include phone jacks, WiFi, and LAN connections and also some traffic management functionality that routes voice traffic to higher class of services than non-voice data. The wireless hotspot can then map communications with higher classes of service to dedicated bearers with guaranteed bitrates, and the lower classes of service to dedicated bearers with non-guaranteed bitrates or even default bearers.
    Type: Grant
    Filed: April 1, 2015
    Date of Patent: September 4, 2018
    Assignees: AT&T Intellectual Property I, L.P., AT&T Mobility II LLC
    Inventors: Howard Lawrence Lang, Steven Rocconi, James Compton, Rajeev Singh, Vimal Patel
  • Publication number: 20180200272
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Application
    Filed: January 19, 2018
    Publication date: July 19, 2018
    Applicant: Nestle Skin Health SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi
  • Publication number: 20180200270
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Publication number: 20180200271
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Application
    Filed: March 15, 2018
    Publication date: July 19, 2018
    Inventors: Ankit BAHETI, Bijay Kumar PADHI, Supritha VAKADA, Rajeev Singh RAGHUVANSHI
  • Patent number: 9949990
    Abstract: The present invention relates to a stable oral liquid pharmaceutical composition of celecoxib or its pharmaceutically acceptable salts thereof. The celecoxib present in the compositions as described herein do not show any precipitation when subjected in Fasted-State Simulated Gastric Fluid (FaSSGF) at pH 2.0, temperature of 37° C.±0.5° C. and under stirring at a speed of 50 rpm at least for 60 minutes. It also relates to the process of preparing and method of using said composition of celecoxib.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: April 24, 2018
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Supritha Vakada, Rajeev Singh Raghuvanshi
  • Patent number: 9901588
    Abstract: Doxycycline formulations with a reduced food effect are disclosed. Particularly disclosed are modified release formulations which can be administered once a day and exhibit a reduced food effect. Methods of treating inflammatory conductions such as rosacea or inflammatory symptoms such as the papules and pustules of rosacea or acne vulgaris are also disclosed.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: February 27, 2018
    Assignee: Nestlé Skin Health SA
    Inventors: Ankit Baheti, Bijay Kumar Padhi, Rajeev Singh Raghuvanshi